ARTG Entry

GANVADO

ARTG entry for GANVADO (Denosumab), ARTG 461905 — Product Information, dosage form, registration history. Compiled by arcimedes.

• Sponsor: Amgen
• Active ingredient: Denosumab
• Therapeutic area: Oncology

TGA Public Summary — ARTG 461905